Getting A Jump On MoCRA Compliance; Due Diligence Now Will Lighten Load, Risks Later

Cosmetics companies should not sit idly waiting for FDA to clarify new requirements under the Modernization of Cosmetic Regulations Act, speakers agreed at the Independent Beauty Association’s 2023 Technical/Regulatory Forum. Companies should be reviewing products, people and processes, including those of contract manufacturers, to get ahead of the curve.

There are numerous unknowns as to how the US Food and Drug Administration will implement aspects of the Modernization of Cosmetic Regulations Act, but that doesn’t mean that cosmetic marketers and manufacturers shouldn’t be taking action to position themselves for compliance.

Gap analysis, “taking a step back to really assess where you are and what information you have,” is the most...